Agreement - December 20, 2016
UIC and Turku Life Science Accelerator collaborate
Uppsala Innovation Centre (UIC) has signed an agreement with the newly established Turku Life Science accelerator, the first Finnish accelerator with a life science focus. The aim with the collaboration is to increase the possibilities for synergies, business and knowledge exchange betwwen companies in Finland and Sweden. UIC and Turku Life Science accelerator has signed […]
Science article - December 19, 2016
Y chromosome loss links to cancer and Alzheimer’s
Men have a shorter lifespan than women and Uppsala University researchers might have an explanation. Why do women tend to live longer than men? Why do men have higher cancer risks than women? Research led by Professor Jan Dumanski and Assistant Professor Lars Forsberg, Department of Immunology, Genetics and Pathology, Uppsala University, suggests that loss […]
Agreement - December 16, 2016
Gyros signs distribution agreement
Gyros Protein Technologies has appointed Abacus ALS as exclusive distributor of its immunoassay products in Australia and New Zealand. Abacus ALS, an ISO 9001: 2008 accredited organization, is one of Australia’s and New Zealand’s largest privately owned companies serving customers in the diagnostic pathology, research and healthcare education industries. Abacus ALS will be responsible for […]
Uncategorized - December 9, 2016
Single gene found connected to many diseases
Genetic differences in the FADS1 gene determine the risk for many different diseases. The ability to produce polyunsaturated fats like omega-3 and omega-6 differs between individuals and this affects the risk for disturbed metabolism, inflammatory diseases and several types of cancer. Scientists at Uppsala University and SciLifeLab in Sweden have clarified this in detail and […]
Drug development - December 7, 2016
Swedish drug development on the rise
Earlier today, SwedenBIO presented its annual report on the Swedish drug discovery and development pipeline, showing for example that the number of clinical stage drug development projects has increased from 63 to 144 in 5 years. The report provides facts and figures about the current Swedish drug development pipeline for drugs intended for use in […]
Collaboration - December 6, 2016
Round table discussion on cross-border cancer research
Last thursday, over 20 healthcare stakeholders, experts and politicians gather in Stockholm for a round table discussion on increasing collaboration on cross-border cancer research and innovation between Sweden and the United States, in order to improve patient outcomes. The roundtable was hosted by the U.S. Ambassador Azita Raji and the Swedish Minister for Higher Education and […]